Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Li, Zhiguo  [Clear All Filters]
Journal Article
Daniel AR, Su C, Williams NT, Li Z, Huang J, Lopez O, Luo L, Ma Y, Campos Lda Silva, Selitsky SR, et al. Transient knockdown of p53 during focal limb irradiation increases the development of sarcomas. Cancer Res Commun. 2023.
Lin C, DiCioccio RA, Haykal T, McManigle WC, Li Z, Anand SM, Poe JC, Bracken SJ, Jia W, Alyea EP, et al. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease: SYK Inhibition in Chronic GVHD. Transplant Cell Ther. 2022.
Chen C, Zheng H, Horwitz EM, Ando S, Araki K, Zhao P, Li Z, Ford ML, Ahmed R, Qu C-K. Mitochondrial metabolic flexibility is critical for CD8 T cell antitumor immunity. Sci Adv. 2023;9(49):eadf9522.
Yao N, Li Y, Han J, Wu S, Liu X, Wang Q, Li Z, Shi F-D. Microglia-derived CCL20 deteriorates neurogenesis following intraventricular hemorrhage. Exp Neurol. 2023:114561.
Paul B, Zhao Y, Loitsch G, Feinberg D, Mathews P, Barak I, Dupuis M, Li Z, Rein L, Wang E, et al. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors. Cancer Med. 2020.
Bracken SJ, Suthers A, DiCioccio RA, Su H, Anand S, Poe JC, Jia W, Visentin J, Basher F, Jordan CZ, et al. Heightened TLR7 Primes BCR-Activated Cells in Chronic Graft-Versus-Host Disease for Effector Functions. Blood Adv. 2023.
Yan Y, Chen C, Li Z, Zhang J, Park N, Qu C-K. Extracellular arginine is required but the arginine transporter CAT3 (Slc7a3) is dispensable for mouse normal and malignant hematopoiesis. Sci Rep. 2022;12(1):21832.
Jia W, Poe JC, Su H, Anand S, Matsushima GK, Rathmell JC, Maillard I, Radojcic V, Imai K, Reyes NJ, et al. BAFF Promotes Heightened BCR Responsiveness and Manifestations of Chronic GVHD after Allogeneic Stem Cell Transplantation. Blood. 2021.